A study to compare the effects on laryngotracheal morbidity of air, 2 percent alkalinized lignocaine and dexamethasone used for endotracheal tube cuff inflation, a randomized control trial.

Endotracheal intubation often causes several postoperative laryngotracheal morbidities like sore throat, cough, dysphagia, hoarseness of voice. Different medications and techniques have been adopted to relieve these complications. Injecting alkalinized lignocaine into endotracheal tube cuff has already shown promising results in various studies. Injection Ketamine used intracuff also gave comparable results, but studies on intracuff dexamethasone are very few. Dexamethasone is a potent corticosteroid with analgesic, anti-inflammatory, and antiemetic properties. Preoperative IV dexamethasone has been reported to reduce the incidence of postoperative pain and swelling following oral surgeries. Even when used intracuff, dexamethasone yielded favorable results in the few studies that we have come across. Therefore, we wish study the effects of injection Dexamethasone against 2% alkalinized Lignocaine when used as an intracuff reservoir in relieving laryngotracheal morbidities.